234 related articles for article (PubMed ID: 31226551)
1. Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.
Itabashi R; Shigehatake Y; Yazawa Y; Endo K; Saito T; Fukuma K; Furui E; Mori E
J Neurol Sci; 2019 Aug; 403():59-64. PubMed ID: 31226551
[TBL] [Abstract][Full Text] [Related]
2. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
Sauser K; Levine DA; Nickles AV; Reeves MJ
JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
[TBL] [Abstract][Full Text] [Related]
3. Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.
Kamal N; Holodinsky JK; Stephenson C; Kashayp D; Demchuk AM; Hill MD; Vilneff RL; Bugbee E; Zerna C; Newcommon N; Lang E; Knox D; Smith EE
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096208
[TBL] [Abstract][Full Text] [Related]
4. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
[TBL] [Abstract][Full Text] [Related]
5. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
[TBL] [Abstract][Full Text] [Related]
6. Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience.
Mowla A; Doyle J; Lail NS; Rajabzadeh-Oghaz H; Deline C; Shirani P; Ching M; Crumlish A; Steck DA; Janicke D; Levy EI; Sawyer RN
J Neurol Sci; 2017 May; 376():102-105. PubMed ID: 28431590
[TBL] [Abstract][Full Text] [Related]
7. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
[TBL] [Abstract][Full Text] [Related]
8. Reducing in-hospital delay to 20 minutes in stroke thrombolysis.
Meretoja A; Strbian D; Mustanoja S; Tatlisumak T; Lindsberg PJ; Kaste M
Neurology; 2012 Jul; 79(4):306-13. PubMed ID: 22622858
[TBL] [Abstract][Full Text] [Related]
9. Collaborative Interventions Reduce Time-to-Thrombolysis for Acute Ischemic Stroke in a Public Safety Net Hospital.
Threlkeld ZD; Kozak B; McCoy D; Cole S; Martin C; Singh V
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1500-1505. PubMed ID: 28396187
[TBL] [Abstract][Full Text] [Related]
10. Generalization of the right acute stroke promotive strategies in reducing delays of intravenous thrombolysis for acute ischemic stroke: A meta-analysis.
Huang Q; Zhang JZ; Xu WD; Wu J
Medicine (Baltimore); 2018 Jun; 97(25):e11205. PubMed ID: 29924046
[TBL] [Abstract][Full Text] [Related]
11. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
[TBL] [Abstract][Full Text] [Related]
12. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
[TBL] [Abstract][Full Text] [Related]
13. Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes.
Tran D; Zhu Z; Shafie M; Abcede H; Stradling D; Yu W
BMC Neurol; 2019 Nov; 19(1):300. PubMed ID: 31771530
[TBL] [Abstract][Full Text] [Related]
14. CODE FAST: a quality improvement initiative to reduce door-to-needle times.
Busby L; Owada K; Dhungana S; Zimmermann S; Coppola V; Ruban R; Horn C; Rochestie D; Khaldi A; Hormes JT; Gupta R
J Neurointerv Surg; 2016 Jul; 8(7):661-4. PubMed ID: 26089402
[TBL] [Abstract][Full Text] [Related]
15. Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.
Prabhakaran S; Lee J; O'Neill K
Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):585-92. PubMed ID: 27625405
[TBL] [Abstract][Full Text] [Related]
16. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Pretnar Oblak J; Sabovic M; Frol S
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
[TBL] [Abstract][Full Text] [Related]
20. Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.
Medlin F; Amiguet M; Vanacker P; Michel P
Stroke; 2015 Jan; 46(1):126-31. PubMed ID: 25424477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
